| 28th Feb 2025 12:00 pm |
RNS |
Notice of Annual General Meeting |
| 27th Feb 2025 7:30 am |
RNS |
Positive EMA Opinion on Orphan Drug Designation |
| 27th Feb 2025 7:15 am |
RNS |
Annual Report 2024 published |
| 27th Feb 2025 7:00 am |
RNS |
Financial Statement 1 January to 31 December 2024 |
| 19th Feb 2025 10:00 am |
RNS |
Notice of Financial Statement and Annual Report |
| 14th Feb 2025 12:00 pm |
RNS |
Holding(s) in Company |
| 11th Feb 2025 7:30 am |
RNS |
Change of Broker |
| 6th Feb 2025 3:00 pm |
RNS |
Holding(s) in Company |
| 6th Feb 2025 7:00 am |
RNS |
Results of Oversubscribed Placing |
| 5th Feb 2025 4:30 pm |
RNS |
Proposed Issue and Placing |
| 31st Jan 2025 7:00 am |
RNS-R |
Final Patient Identified for BEXMAB Phase II Study |
| 13th Dec 2024 7:00 am |
RNS |
Faron’s Financial Calendar for 2025 |
| 27th Nov 2024 7:00 am |
RNS |
Positive Phase 2 Interim Results from BEXMAB Trial |
| 5th Nov 2024 7:00 am |
RNS |
Shareholders’ Nomination Board |
| 22nd Oct 2024 7:00 am |
RNS |
Faron’s Capital Markets Day 2024 |
| 30th Aug 2024 7:00 am |
RNS |
Grant of options |
| 27th Aug 2024 7:00 am |
RNS |
Faron 2024 Half-Year Financial Results |
| 27th Aug 2024 7:00 am |
RNS |
FDA Grants Fast Track Designation for Bexmarilimab |
| 20th Aug 2024 7:00 am |
RNS |
Notice of Half-Year Financial Results |
| 8th Aug 2024 7:00 am |
RNS |
Appointment of Chief Financial Officer |
| 7th Aug 2024 10:00 am |
RNS |
Grant of options |
| 6th Aug 2024 8:30 am |
RNS |
Faron Appoints Dr. Petri Bono as new CMO |
| 11th Jul 2024 7:00 am |
RNS |
Faron Announces Positive FDA Feedback |
| 25th Jun 2024 2:00 pm |
RNS |
Update on settlement |
| 25th Jun 2024 10:30 am |
RNS |
Holding(s) in Company - Replacement |
| 24th Jun 2024 12:45 pm |
RNS |
Holding(s) in Company |
| 24th Jun 2024 12:45 pm |
RNS |
Holding(s) in Company |
| 24th Jun 2024 12:45 pm |
RNS |
Holding(s) in Company |
| 24th Jun 2024 12:45 pm |
RNS |
Holding(s) in Company |
| 20th Jun 2024 1:00 pm |
RNS |
New shares registered with Finnish Trade Register |
| 20th Jun 2024 7:00 am |
RNS |
Fully subscribed EUR 30.7 million share offering |
| 5th Jun 2024 8:00 am |
RNS |
Proposed REX Retail Offer |
| 4th Jun 2024 7:00 am |
RNS |
Faron commences a share offering |
| 20th May 2024 7:00 am |
RNS |
Initial positive data from Phase 2 of BEXMAB |
| 17th May 2024 4:00 pm |
RNS |
Issuance of warrants |
| 16th May 2024 7:05 am |
RNS |
Founders named European Inventor Award finalists |
| 13th May 2024 7:00 am |
RNS |
Replacement – Board Change |
| 30th Apr 2024 2:00 pm |
RNS |
Update on financial status |
| 30th Apr 2024 1:00 pm |
RNS |
Board Change |
| 16th Apr 2024 7:00 am |
RNS |
Faron confirms plans under new leadership |
